10-Q 1 g79151e10vq.htm HEALTHCARE REALTY TRUST, INC. e10vq
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q

     
(Mark One)    
     
[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
     
    For the quarterly period ended: September 30, 2002
     
    OR
     
[  ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
     
    For the transition period from                to                

Commission File Number: 1-11852


HEALTHCARE REALTY TRUST INCORPORATED

(Exact name of Registrant as specified in its charter)
     
Maryland
(State or other jurisdiction of
incorporation or organization)
  62 – 1507028
(I.R.S. Employer
Identification No.)

3310 West End Avenue
Suite 700
Nashville, Tennessee 37203

(Address of principal executive offices)

(615) 269-8175
(Registrant’s telephone number, including area code)

     Indicate by check mark whether the Registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]         No [   ]

     As of November 1, 2002, 42,118,351 shares of the Registrant’s Common Stock were outstanding.

 


Part I. FINANCIAL INFORMATION
Consolidated Balance Sheets
Consolidated Statements of Income
Consolidated Statements of Cash Flows
Notes to Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of
Financial Condition and Results of Operations
Item 4. Controls and Procedures
PART II — OTHER INFORMATION
Item 6. Reports on Form 8-K
SIGNATURE
Certifications


Table of Contents

HEALTHCARE REALTY TRUST
INCORPORATED

FORM 10-Q

September 30, 2002

TABLE OF CONTENTS

                         
                    Page
Part I - Financial Information
             
 
  Item 1. Financial Statements     1
 
          Consolidated Balance Sheets     1  
 
          Consolidated Statements of Income     2  
 
          Consolidated Statements of Cash Flows     4  
 
          Notes to Consolidated Financial Statements     5  
 
  Item 2. Management's Discussion and Analysis of Financial Condition        
 
          and Results of Operations     12  
 
  Item 4. Controls and Procedures     20  
Part II - Other Information
           
 
  Item 6. Reports on Form 8-K     21  
Signature
                22  
Certifications
              23  

 


Table of Contents

Part I. FINANCIAL INFORMATION

Healthcare Realty Trust Incorporated

Consolidated Balance Sheets
(Dollars in thousands)
                     
        (Unaudited)        
        September 30,   December 31,
        2002   2001
       
 
ASSETS
               
Real estate properties:
               
 
Land
  $ 135,240     $ 149,522  
 
Buildings and improvements
    1,321,558       1,348,031  
 
Personal property
    8,486       7,815  
 
Construction in progress
    9,911       18,255  
 
   
     
 
 
    1,475,195       1,523,623  
 
Less accumulated depreciation
    (185,999 )     (160,886 )
 
   
     
 
   
Total real estate properties, net
    1,289,196       1,362,737  
Cash and cash equivalents
    2,743       2,930  
Mortgage notes receivable
    107,940       122,074  
Other assets, net
    91,291       67,740  
 
   
     
 
Total assets
  $ 1,491,170     $ 1,555,481  
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Liabilities:
               
 
Notes and bonds payable
  $ 534,849     $ 505,222  
 
Accounts payable and accrued liabilities
    19,966       12,203  
 
Other liabilities
    13,223       25,969  
 
   
     
 
Total liabilities
    568,038       543,394  
 
   
     
 
Commitments
    0       0  
Stockholders’ equity:
               
 
Preferred stock, $.01 par value; 50,000,000 shares authorized; issued and outstanding, 2002 - none; 2001 - 3,000,000
    0       30  
 
Common stock, $.01 par value; 150,000,000 shares authorized; issued and outstanding, 2002 – 41,968,351; 2001 – 41,465,919
    419       414  
 
Additional paid-in capital
    1,027,670       1,089,127  
 
Deferred compensation
    (22,505 )     (12,852 )
 
Cumulative net income
    437,654       375,061  
 
Cumulative dividends
    (520,106 )     (439,693 )
 
   
     
 
Total stockholders’ equity
    923,132       1,012,087  
 
   
     
 
Total liabilities and stockholders’ equity
  $ 1,491,170     $ 1,555,481  
 
   
     
 

The accompanying notes, together with the Notes to the Consolidated Financial
Statements included in our Annual Report on Form 10-K for the year ended
December 31, 2001, are an integral part of these financial statements.

1


Table of Contents

Healthcare Realty Trust Incorporated

Consolidated Statements of Income
For The Three Months Ended September 30, 2002 and 2001
(Dollars in thousands, except per share data)
                   
      (Unaudited)   (Unaudited)
      2002   2001
     
 
REVENUES:
               
 
Master lease rental income
  $ 25,276     $ 24,941  
 
Property operating income
    19,626       15,783  
 
Straight-line rental income
    1,017       1,289  
 
Mortgage interest income
    3,292       4,669  
 
Management fee income
    257       396  
 
Interest and other income
    350       740  
 
   
     
 
 
    49,818       47,818  
EXPENSES:
               
 
General and administrative expense
    3,140       2,772  
 
Property operating expense
    7,486       6,288  
 
Interest expense
    8,529       9,161  
 
Depreciation expense
    10,386       10,216  
 
Amortization expense
    29       74  
 
   
     
 
 
    29,570       28,511  
 
   
     
 
NET INCOME BEFORE NET GAIN (LOSS) ON SALE OF REAL ESTATE PROPERTIES
    20,248       19,307  
NET GAIN (LOSS) ON SALE OF REAL ESTATE PROPERTIES
    242       416  
 
   
     
 
NET INCOME
  $ 20,490     $ 19,723  
 
   
     
 
NET INCOME PER COMMON SHARE – BASIC
  $ 0.45     $ 0.45  
 
   
     
 
NET INCOME PER COMMON SHARE – DILUTED
  $ 0.44     $ 0.45  
 
   
     
 
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING – BASIC
    40,682,210       39,891,254  
 
   
     
 
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING – DILUTED
    41,487,797       40,512,989  
 
   
     
 
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD
  $ 0.600     $ 0.580  
 
   
     
 

The accompanying notes, together with the Notes to the Consolidated Financial
Statements included in our Annual Report on Form 10-K for the year ended
December 31, 2001, are an integral part of these financial statements.

2


Table of Contents

Healthcare Realty Trust Incorporated
Consolidated Statements of Income
For The Nine Months Ended September 30, 2002 and 2001

(Dollars in thousands, except per share data)

                   
      (Unaudited)   (Unaudited)
      2002   2001
     
 
REVENUES:
               
 
Master lease rental income
  $ 74,855     $ 75,053  
 
Property operating income
    57,627       49,822  
 
Straight-line rental income
    2,248       4,480  
 
Mortgage interest income
    10,614       13,714  
 
Management fee income
    850       1,120  
 
Interest and other income
    1,587       1,353  
 
   
     
 
 
    147,781       145,542  
EXPENSES:
               
 
General and administrative expense
    8,374       7,565  
 
Property operating expense
    22,348       19,151  
 
Interest expense
    25,966       29,360  
 
Depreciation expense
    31,267       30,496  
 
Amortization expense
    105       229  
 
   
     
 
 
    88,060       86,801  
 
   
     
 
NET INCOME BEFORE NET GAIN (LOSS) ON SALE OF REAL ESTATE PROPERTIES
    59,721       58,741  
NET GAIN (LOSS) ON SALE OF REAL ESTATE PROPERTIES
    2,872       999  
 
   
     
 
NET INCOME
  $ 62,593     $ 59,740  
 
   
     
 
NET INCOME PER COMMON SHARE – BASIC
  $ 1.40     $ 1.38  
 
   
     
 
NET INCOME PER COMMON SHARE – DILUTED
  $ 1.38     $ 1.36  
 
   
     
 
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING – BASIC
    40,601,065       39,748,243  
 
   
     
 
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING – DILUTED
    41,450,671       40,404,491  
 
   
     
 
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD
  $ 1.785     $ 1.725  
 
   
     
 

The accompanying notes, together with the Notes to the Consolidated Financial
Statements included in our Annual Report on Form 10-K for the year ended
December 31, 2001, are an integral part of these financial statements.

3


Table of Contents

Healthcare Realty Trust Incorporated

Consolidated Statements of Cash Flows
For The Nine Months Ended September 30, 2002 and 2001
(Dollars in thousands)
                     
        (Unaudited)   (Unaudited)
        2002   2001
       
 
Cash flows from operating activities:
               
 
Net income
  $ 62,593     $ 59,740  
 
Adjustments to reconcile net income to cash provided by operating activities:
               
   
Depreciation and amortization
    32,816       32,285  
   
Deferred compensation amortization
    2,301       1,395  
   
Decrease in other liabilities
    (919 )     (225 )
   
Increase in other assets
    (7,281 )     (18,999 )
   
Increase in accounts payable and accrued liabilities
    7,758       2,600  
   
Increase in straight line rent
    (2,248 )     (4,335 )
   
Net gain on sales of real estate
    (2,872 )     (999 )
 
   
     
 
 
Net cash provided by operating activities
    92,148       71,462  
Cash flows from investing activities:
               
 
Acquisition and development of real estate properties
    (21,176 )     (42,088 )
 
Funding of mortgages
    (3,921 )     (2,911 )
 
Proceeds from sale of real estate
    67,485       19,515  
 
Proceeds from mortgage payments/sales
    17,578       42,766  
 
   
     
 
 
Net cash provided by investing activities
    59,966       17,282  
Cash flows from financing activities:
               
 
Borrowings on notes and bonds payable
    166,500       470,652  
 
Repayments on notes and bonds payable
    (164,957 )     (488,083 )
 
Dividends paid
    (80,413 )     (75,062 )
 
Preferred stock redemption
    (75,000 )     0  
 
Proceeds from issuance of common stock
    1,569       4,272  
 
   
     
 
 
Net cash used in financing activities
    (152,301 )     (88,221 )
 
   
     
 
Increase (decrease) in cash and cash equivalents
    (187 )     523  
Cash and cash equivalents, beginning of period
    2,930       1,788  
 
   
     
 
Cash and cash equivalents, end of period
  $ 2,743     $ 2,311  
 
   
     
 

The accompanying notes, together with the Notes to the Consolidated Financial
Statements included in our Annual Report on Form 10-K for the year ended
December 31, 2001, are an integral part of these financial statements.

4


Table of Contents

Healthcare Realty Trust
Incorporated

Notes to Consolidated Financial Statements

September 30, 2002

(Unaudited)

Note 1. Significant Accounting Policies

     The accompanying unaudited consolidated financial statements and notes have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements that are included in our Annual Report to Shareholders on Form 10-K for the year ended December 31, 2001. We, the management of Healthcare Realty Trust, believe however that all adjustments considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2002 due to many reasons including, but not limited to, acquisitions, dispositions and changes in interest rates.

     References to “the Company”, “we”, “our” and “us” include Healthcare Realty Trust Incorporated and its consolidated subsidiaries and partnerships unless otherwise stated.

     We recommend and presume that users of this interim financial information have access to and have read or will read in conjunction with this interim information our audited financial statements and Management’s Discussion and Analysis of Financial Condition and Results of Operations for the year ended December 31, 2001.

Reclassifications

     We have made certain reclassifications in the financial statements for 2001 to conform to the 2002 presentation. These reclassifications did not change the results of operations as previously reported.

New pronouncements

     In July 2001, the Financial Accounting Standards Board issued Statement No. 142, “Accounting for Goodwill and Intangible Assets” (“FAS 142”). FAS 142 became effective for us as of January 1, 2002. FAS 142 requires that we no longer amortize goodwill and other indefinite lived intangible assets but that we review these assets annually for impairment. Intangible assets with definite lives will continue to be amortized. The adoption of FAS 142 had no material impact on our financial statements as of September 30, 2002 or for the three and nine month periods then ended.

5


Table of Contents

Note 2. Properties

     We invest in healthcare-related properties and mortgages located throughout the United States. We provide management, leasing and build-to-suit development services, and capital for the construction of new facilities and the acquisition of existing properties. These activities constitute a single business segment as defined by the Financial Accounting Standards Board Statement No. 131, “Disclosures about Segments of an Enterprise and Related Information.” As of September 30, 2002, we had investments in 223 properties and mortgages, located in 29 states, and affiliated with 62 healthcare-related operators as follows:

                         
    Number of   (in thousands)        
    Properties   Investment   Percent
   
 
 
Ancillary hospital facilities
    56     $ 492,757       31.1 %
Assisted living facilities
    53       276,778       17.5 %
Skilled nursing facilities
    37       204,452       12.9 %
Inpatient rehabilitation facilities
    9       156,053       9.9 %
Physician clinics
    29       153,684       9.7 %
Comprehensive ambulatory care centers
    13       151,332       9.6 %
Medical office buildings
    9       48,096       3.0 %
Other inpatient facilities
    5       47,555       3.0 %
Other outpatient facilities
    12       42,957       2.7 %
Corporate property
          9,471       0.6 %
 
   
     
     
 
 
    223     $ 1,583,135       100.0 %
 
   
     
     
 

Dispositions

     During the third quarter of 2002, we sold three ancillary hospital facilities totaling 201,600 square feet in Richmond, Virginia; a 21,120 square foot assisted living facility in West Columbia, South Carolina; a 44,300 square foot physician clinic in Methuen, Massachusetts; and a 41,880 square foot physician clinic in Birmingham, Alabama for aggregate net proceeds totaling approximately $46.4 million resulting in a net gain of approximately $242,000. Further, we received approximately $5.7 million in net proceeds from the repayment of four mortgage notes.

Note 3. Funds From Operations

     Funds from operations, as defined by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”) 1999 White Paper, means net income before net gains (or losses) from sales of real estate properties (computed in accordance with accounting principles generally accepted in the United States) plus depreciation from real estate assets. We calculate funds from operations (“FFO”) using a modified version of the NAREIT’s October 1999 definition of funds from operations. We eliminate straight-line rental revenue in computing FFO although

6


Table of Contents

NAREIT’s definition of funds from operations requires the inclusion of straight-line rental revenue in funds from operation.

     We consider FFO to be an informative measure of the performance of an equity real estate investment trust (“REIT”) and consistent with measures used by analysts to evaluate equity REITs. FFO does not represent cash generated from operating activities in accordance with accounting principles generally accepted in the United States, is not necessarily indicative of cash available to fund cash needs, and should not be considered as an alternative to net income as an indicator of our operating performance or as an alternative to cash flow as a measure of liquidity. We believe that our FFO is not directly comparable to other healthcare REITs, which own a portfolio of triple net leased properties or mortgages, as we develop projects through a development and lease-up phase before they reach their targeted cash flow returns. Furthermore, we eliminate, in consolidation, fee income for developing, leasing and managing owned properties and expenses or capitalizes, as the case may be, related internal costs. Our FFO calculations for the three and nine month periods ended September 30, 2002 and 2001 are shown in the following two tables.

Funds From Operations

(Dollars in thousands, except per share data)

                   
      Three Months Ended September 30,
     
      2002   2001
     
 
Net income before net gain (loss) on sale of real estate properties
  $ 20,248     $ 19,307  
 
Certain debt-related charges (1)
    0       607  
 
Elimination of rental revenues recognized on a straight-line basis (1)
    (1,017 )     (1,289 )
 
Preferred stock dividend (1)
    (1,664 )     (1,664 )
 
Real estate depreciation
    10,094       10,007  
 
   
     
 
 
Total adjustments
    7,413       7,661  
 
   
     
 
Funds From Operations-Basic and Diluted
  $ 27,661     $ 26,968  
 
   
     
 
Funds From Operations Per Common Share – Basic
  $ 0.68     $ 0.68  
 
   
     
 
Funds From Operations Per Common Share – Diluted
  $ 0.67     $ 0.67  
 
   
     
 
Weighted Average Common Shares Outstanding – Basic
    40,682,210       39,891,254  
 
   
     
 
Weighted Average Common Shares Outstanding – Diluted
    41,487,797       40,512,989  
 
   
     
 


(1)   We calculate our FFO using a modified version of National Association of Real Estate Investment Trust’s (“NAREIT”) October 1999 definition of funds from operations. We eliminate straight-line rental revenue in computing FFO although NAREIT’s definition of funds from operations requires the inclusion of straight-line rental revenue. Also, in 2002, we included only three months of preferred stock dividends in computing FFO although an additional amount was paid upon redemption of the preferred stock on September 30, 2002. In 2001, we also excluded certain debt-related charges in computing FFO. If we had followed the NAREIT definition of funds from operations, as other healthcare REITs do, FFO on a diluted basis would have been $0.68 per common share for the three months ended September 30, 2002.
 
   

7


Table of Contents

Funds From Operations

(Dollars in thousands, except per share data)

                   
      Nine Months Ended September 30,
     
      2002   2001
     
 
Net income before net gain (loss) on sale of real estate properties
  $ 59,721     $ 58,741  
 
Certain debt-related charges (1)
    0       607  
 
Elimination of rental revenues recognized on a straight-line basis (1)
    (2,248 )     (4,480 )
 
Preferred stock dividend (1)
    (4,992 )     (4,992 )
 
Real estate depreciation
    30,411       29,949  
 
   
     
 
 
Total adjustments
    23,171       21,084  
 
   
     
 
Funds From Operations-Basic and Diluted
  $ 82,892     $ 79,825  
 
   
     
 
Funds From Operations Per Common Share – Basic
  $ 2.04     $ 2.01  
 
   
     
 
Funds From Operations Per Common Share – Diluted
  $ 2.00     $ 1.98  
 
   
     
 
Weighted Average Common Shares Outstanding – Basic
    40,601,065       39,748,243  
 
   
     
 
Weighted Average Common Shares Outstanding – Diluted
    41,450,671       40,404,491  
 
   
     
 


(1)   We calculate our FFO using a modified version of National Association of Real Estate Investment Trust’s (“NAREIT”) October 1999 definition of funds from operations. We eliminate straight-line rental revenue in computing FFO although NAREIT’s definition of funds from operations requires the inclusion of straight-line rental revenue. Also, in 2002, we included only nine months of preferred stock dividends in computing FFO although an additional amount was paid upon redemption of the preferred stock on September 30, 2002. In 2001, we also excluded certain debt-related charges in computing FFO. If we had followed the NAREIT definition of funds from operations, as other healthcare REITs do, FFO on a diluted basis would have been $2.04 per common share for the nine months ended September 30, 2002.

Note 4. Notes and Bonds Payable

     Notes and bonds payable at September 30, 2002 consisted of the following (in thousands):

         
Unsecured Credit Facility due 2004
  $ 73,000  
Senior Notes due 2002
    0  
Senior Notes due 2006
    70,000  
Senior Notes due 2011, net
    315,163  
Mortgage notes payable
    73,186  
Other note payable
    3,500  
 
   
 
 
  $ 534,849  
 
   
 

8


Table of Contents

Unsecured Credit Facility due 2004

     In July 2001, we entered into a $150.0 million credit facility (the “Unsecured Credit Facility due 2004”) that bears interest at LIBOR rates plus 1.15%, payable quarterly, and matures in July 2004. In addition, we pay a facility fee of 0.2% on the commitment. The Unsecured Credit Facility due 2004 contains certain representations, warranties, and financial and other covenants customary in such loan agreements. At October 31, 2002, we had borrowing capacity remaining of $84.0 million under this facility.

Senior Notes due 2002

     In 1995, we privately placed $90.0 million of unsecured senior notes (the “Senior Notes due 2002”). These notes were fully repaid upon maturity on September 1, 2002.

Senior Notes due 2006

     In 2000, we privately placed $70.0 million of unsecured senior notes (the “Senior Notes due 2006”) with multiple purchasers affiliated with two institutions. The Senior Notes due 2006 bear interest at 9.49%, payable semi-annually, and mature on April 1, 2006. On April 1, 2004 and 2005, we must repay $20.3 million of the principal with the remaining principal balance of $29.4 million payable upon maturity. The note agreements pertaining to the Senior Notes due 2006 contain certain representations, warranties and financial and other covenants customary in such loan agreements.

Senior Notes due 2011

     In May 2001, we publicly issued $300.0 million unsecured senior notes due 2011 (the “Senior Notes due 2011”). The Senior Notes due 2011 bear interest at 8.125%, payable semi-annually on May 1 and November 1, and are due on May 1, 2011, unless we redeem them earlier. The notes were issued at a discount of approximately $1.5 million, yielding an 8.202% interest rate per annum.

Interest Rate Swaps

     Following the reorganization of our debt structure in 2001, our outstanding debt was primarily fixed rate. Our practice and objective has been to protect ourselves against changes in the fair value of our debt that result from changes in market interest rates by maintaining a mix of variable and fixed rate debt. In order to accomplish this objective, in June 2001, we entered into interest rate swap agreements with two lending institutions for notional amounts totaling $125.0 million which are expected to offset changes in the fair value of $125.0 million of the Senior Notes due 2011. In both interest rate swaps, we receive a 8.125% fixed rate and pay a variable rate of LIBOR plus 1.99%. The swaps are not callable for the first five years. After five years, the swaps are callable, at fair value, by either party if, and only if, the other party is downgraded below investment grade by two or more rating agencies. These derivative instruments meet all requirements of a fair value hedge and are accounted for using the “shortcut method” as set forth in Financial Accounting Standards Board Statement No. 133. As such, changes in fair value will have no impact on the income statement. At September 30, 2002, the aggregate fair value totaling $16.6 million of our hedge is reported in other assets with an offsetting increase to the Senior Notes due 2011 included in notes and bonds payable on our balance sheet.

9


Table of Contents

Mortgage Notes Payable

     At September 30, 2002, we had 13 non-recourse mortgage notes payable outstanding, with related collateral, as follows (dollars in millions):

                                                 
                                    Investment in   Contractual
            Effective   Maturity           Collateral at   Balance at
Mortgagor   Original Balance   Interest Rate   Date   Collateral   Sept. 30, 2002   Sept. 30, 2002

 
 
 
 
 
 
Life Insurance Co.
  $ 23.3       7.765 %     7/26     Ancillary hospital   $ 43.8     $ 21.9  
 
                          facility                
Life Insurance Co.
    4.7       7.765 %     1/17     Ancillary hospital     10.8       4.0  
 
                          facility                
Life Insurance Co.
    17.1       7.765 %     4/04     Two ambulatory surgery     37.7       15.8  
 
                          centers & one ancillary                
 
                          hospital facility                
Commercial Bank
    35.0       7.220 %     5/11     Nine ancillary hospital     78.2       31.5  
 
                          facilities & one                
 
                          physician clinic                
 
                                   
     
 
 
                                  $ 170.5     $ 73.2  
 
                                   
     
 

     The $23.3 million note is payable in monthly installments of principal and interest based on a 30-year amortization with the final payment due in July 2026. The $4.7 million note is payable in monthly installments of principal and interest based on a 20-year amortization with the final payment due in January 2017. The three notes totaling $17.1 million are payable in monthly installments of principal and interest based on a 25-year amortization with a balloon payment of the unpaid balance due in September 2004. The eight notes totaling $35.0 million and the related collateral are held by special purpose entities whose sole members are wholly owned subsidiaries. These eight fully amortizing notes are payable in monthly installments of principal and interest and mature in May 2011. The contractual interest rates for the 13 outstanding mortgage notes range from 7.22% to 8.50%.

Other Note Payable

     In 1999, we entered into a $7.0 million note with a commercial bank. This note bears interest at 7.53%, is payable in equal semi-annual installments of principal and interest, and fully amortizes in July 2005.

Note 5. Commitments and Contingencies

     At September 30, 2002, we had a net investment of approximately $9.9 million in build-to-suit developments in progress that have a total remaining funding commitment of approximately $0.5 million.

     As part of the merger with Capstone Capital Corporation (“Capstone”) in 1998, agreements were entered into with three individuals affiliated with Capstone that restrict competitive practices and which the Company believed would protect and enhance the value of the real estate properties acquired from Capstone. These agreements provide for the issuance of 150,000 shares per year of common stock to these individuals on October 15 of the years 1999, 2000, 2001 and 2002, provided all terms of the agreements are met. We issued 150,000 in each of the four years with the final issuance in October 2002.

10


Table of Contents

Note 6. Earnings Per Common Share

     We compute earnings per share in accordance with FASB Statement No. 128 “Earnings Per Share.” The table below sets forth the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2002 (dollars in thousands, except per share data).

                                         
            Three Months Ended   Nine Months Ended
            September 30,   September 30,
           
 
            2002   2001   2002   2001
           
 
 
 
Basic EPS
                               
 
Weighted Average Common Shares Outstanding
    41,942,781       40,729,439       41,861,636       40,586,428  
     
Actual restricted stock shares
    (1,260,571 )     (838,185 )     (1,260,571 )     (838,185 )
 
   
     
     
     
 
   
Denominator – Basic
    40,682,210       39,891,254       40,601,065       39,748,243  
 
   
     
     
     
 
   
Net income
  $ 20,490     $ 19,723     $ 62,593     $ 59,740  
       
Preferred stock dividend
    (2,231 )     (1,664 )     (5,559 )     (4,992 )
 
   
     
     
     
 
   
Numerator – Basic
  $ 18,259     $ 18,059     $ 57,034     $ 54,748  
 
   
     
     
     
 
   
Per Share Amount
  $ 0.45     $ 0.45     $ 1.40     $ 1.38  
 
   
     
     
     
 
Diluted EPS
                               
   
Weighted Average Common Shares Outstanding
    41,942,781       40,729,439       41,861,636       40,586,428  
     
Actual restricted stock shares
    (1,260,571 )     (838,185 )     (1,260,571 )     (838,185 )
     
Restricted shares – Treasury
    730,923       506,341       748,176       544,116  
     
Dilution for employee stock purchase plan
    74,664       115,394       101,430       112,132  
 
   
     
     
     
 
     
Denominator – Diluted
    41,487,797       40,512,989       41,450,671       40,404,491  
 
   
     
     
     
 
     
Numerator – Basic and Diluted
  $ 18,259     $ 18,059     $ 57,034     $ 54,748  
 
   
     
     
     
 
     
Per Share Amount
  $ 0.44     $ 0.45     $ 1.38     $ 1.36  
 
   
     
     
     
 

Note 7. Redemption of Preferred Stock

     On September 30, 2002, we redeemed all of our 8 7/8% Series A Voting Cumulative Preferred Stock at a redemption price of $25.00 per share, plus accrued dividends of $0.18896 per share from August 30, 2002 to the redemption date, for a total redemption price of $25.18896 per share. The aggregate cost of the redemption was $75,566,881.

Note 8. Subsequent Events

Common Stock Dividend

     On October 22, 2002, our Board of Directors declared a quarterly dividend of $0.605 per common share payable on December 5, 2002 to stockholders of record on November 15, 2002.

11


Table of Contents

Item 2. Management’s Discussion and Analysis of
Financial Condition and Results of Operations

Overview

     Healthcare Realty Trust operates under the Internal Revenue Code of 1986, as amended, as an indefinite life real estate investment trust (“REIT”). We are a self-managed, self-administered REIT following a general growth strategy that integrates owning, managing, and developing income-producing real estate properties and mortgages associated with the delivery of healthcare services throughout the United States. We, the management of Healthcare Realty Trust, believe that by providing related real estate services, we can differentiate our competitive market position and expand our asset base and increase revenues.

     Substantially all of our revenues are derived from rentals on our healthcare properties, from interest earned on mortgage loans and from management services. Leases and other financial support arrangements with operators are designed to reduce our exposure to increased costs and expenses incurred from the operation of our healthcare properties which are typically borne by the tenants and healthcare providers related to the properties. We typically incur operating and administrative expenses, principally compensation expense, office rental and related occupancy costs and various expenses incurred in the process of managing our existing portfolio and acquiring additional properties. We also incur interest expense on our various debt instruments and depreciation expense on our real estate portfolio.

Operating Results

Third Quarter 2002 Compared to Third Quarter 2001

     Net income for the quarter ended September 30, 2002 totaled $20.5 million, or $0.45 per basic common share ($0.44 per diluted common share), on total revenues of $49.8 million. This compares with net income of $19.7 million, or $0.45 per basic and diluted common share, on total revenues of $47.8 million for the quarter ended September 30, 2001. Included in net income for the quarter ended September 30, 2002 is a net gain on sales of real estate properties of $0.2 million, or $0.01 per basic and diluted common share, compared with a net gain on sales of real estate properties during the third quarter of 2001 of $0.4 million, or $0.01 per basic and diluted common share.

     Total revenues for the quarter ended September 30, 2002 compared to the quarter ended September 30, 2001, increased $2.0 million or 4.2% mainly for the reasons discussed below:

     •     Master lease rental income increased $0.3 million or 1.3% due mainly to rent growth from contractual increases and receipt of a lease termination fee, offset partially by the disposition of 11 revenue-producing properties since June 30, 2001.

     •     Property operating income increased $3.8 million or 24.4% due mainly to the acquisition of one revenue-producing property and the commencement of operations during 2001 and 2002 of five properties that were previously under construction and the increased

12


Table of Contents

occupancy in other multi-tenanted properties, offset partially by the disposal of three properties since June 30, 2001.

     •     Straight-line rental income decreased $0.3 million or 21.1%. This decrease was due mainly to normal annual decreases in the straight line rent calculation on our leases as well as restructuring the rent increases in the second quarter of 2002 on four leases at the request of a new operator that eliminated the straight line rent requirement.

     •     Mortgage interest income decreased $1.4 million or 29.5% due mainly to the repayment of 21 mortgage loans since June 30, 2001. This decrease in revenue was offset partially by income earned on a first mortgage acquired in 2002 by the Company on a property where we previously owned the second mortgage.

     •     Management fee income decreased $0.1 million or 35.1% due mainly to a reduction in our property and asset management portfolio by 1.2 million square feet since June 30, 2001.

     •     Interest and other income decreased $0.4 million or 52.7% due mainly to fees earned on mortgage notes receivable repayments during the third quarter of 2001 offset slightly by participating interest paid on a note during 2001 that was repurchased by the Company in January 2002.

     Total expenses for the quarter ended September 30, 2002 compared to the quarter ended September 30, 2001 increased $1.1 million or 3.7% mainly for the reasons discussed below:

     •     General and administrative expenses increased $0.4 million or 13.3% due mainly to an increase in the number of employees and related compensation for portfolio management and other service based activities, an increase in insurance premiums as well as slightly higher state income and franchise tax expense recognized in 2002 while in 2001, we recognized certain debt-related charges.

     •     Property operating expenses increased $1.2 million or 19.1% due mainly to the acquisition of one revenue-producing property and the commencement of operations during 2001 and 2002 of five properties that were previously under construction and the increased occupancy in other multi-tenanted properties, offset partially by the disposal of three properties since June 30, 2001.

     •     Interest expense decreased $0.6 million or 6.9% mainly due to the continuing decrease in market interest rates along with a reduction in total debt outstanding from 2001 to 2002.

Nine Months Ended September 30, 2002 Compared to Nine Months Ended September 30, 2001

     Net income for the nine months ended September 30, 2002 totaled $62.6 million, or $1.40 per basic common share ($1.38 per diluted common share), on total revenues of $147.8 million. This compares with net income of $59.7 million, or $1.38 per basic common share ($1.36 per diluted common share), on total revenues of $145.5 million for the nine months ended September 30, 2001. Included in net income for the nine months ended September 30, 2002 is a

13


Table of Contents

net gain on sales of real estate properties of $2.9 million, or $.07 per basic and diluted common share, compared with a net gain on sales of real estate properties during the same period in 2001 of $1.0 million, or $0.03 per basic common share ($0.02 per diluted common share).

     Total revenues for the nine months ended September 30, 2002 compared to the nine months ended September 30, 2001, increased $2.2 million or 1.5% mainly for the reasons discussed below:

     •     Master lease rental income decreased $0.2 million or 0.3% due mainly to the disposition of 13 revenue-producing properties during 2001 and 2002, offset partially by rent growth from contractual increases, receipt of a lease termination fee and from more assertively billing and collecting late fees in 2002.

     •     Property operating income increased $7.8 million or 15.7% due mainly to the acquisition of one revenue-producing property, the commencement of operations during 2001 and 2002 of five properties that were previously under construction and the increased occupancy in other multi-tenanted properties, offset partially by the disposal of three properties during 2001 and 2002.

     •     Straight-line rental income decreased $2.2 million or 49.8%. This decrease was due mainly to a change in the operator on four assisted living facilities and restructuring the rent increases on these four leases at the request of the new operator during the second quarter of 2002 which resulted in a reversal of the historical straight line rent receivable on those four leases as well as normal annual decreases in the straight line rent calculation on our other leases.

     •     Mortgage interest income decreased $3.1 million or 22.6% due mainly to the repayment of 29 mortgage loans during 2001 and 2002. This decrease in revenue was offset partially by income earned on a first mortgage acquired in 2002 by the Company on a property where we previously owned the second mortgage, from additional interest, and from assertively billing and collecting late fees in 2002.

     •     Management fee income decreased $0.3 million or 24.1% due mainly to a reduction in our property and asset management portfolio by 5.0 million square feet since December 31, 2000.

     •     Interest and other income increased $0.2 million or 17.3%. The major components of interest and other income for the first nine months of 2002 were a fee received related to the assignment of four assisted living facility leases to a new operator, fees earned due to the maturity or repayment of mortgage loans, and interest income on notes receivable. The major components of interest and other income for the first nine months of 2001 were interest income earned on excess cash remaining from the May 2001 sale of the Senior Notes due 2011, fees earned from consulting engagements, interest income on notes receivable, and fees earned from the repayment of mortgage loans, offset partially by participating interest paid on a note that was repurchased by the Company in January 2002.

14


Table of Contents

     Total expenses for the nine months ended September 30, 2002 compared to the nine months ended September 30, 2001 increased $1.3 million or 1.5% mainly for the reasons discussed below:

     •     General and administrative expenses increased $0.8 million or 10.7% due mainly to an increase in the number of employees and related compensation for portfolio management and other service-based activities, an increase in insurance premiums, as well as higher state income and franchise tax expense recognized in 2002 while in 2001, we recognized certain debt-related charges.

     •     Property operating expenses increased $3.2 million or 16.7% due mainly to the acquisition of one revenue-producing property and the commencement of operations during 2001 and 2002 of five properties that were previously under construction and the increased occupancy in other multi-tenanted properties, offset partially by the disposal of three properties during 2001 and 2002.

     •     Interest expense decreased $3.4 million or 11.6% due mainly to the continuing decrease in market interest rates along with a reduction in total debt outstanding from 2001 to 2002.

     •     Depreciation expense increased $0.8 million or 2.5% due mainly to the acquisition of one revenue-producing property, the commencement of operations during 2001 and 2002 of five properties that were previously under construction, a change in the depreciable life of certain land improvements from 15 years to 20 years resulting in a $134,000 one time adjustment that had no material impact on net income or earnings per share, offset partially by the disposal of 16 properties during 2001 and 2002.

     •     Amortization expense decreased $0.1 million or 54.2% due mainly to the adoption of FAS 142 effective January 1, 2002 that required we discontinue amortization of our goodwill (See Note 1 for further details).

Liquidity and Capital Resources

Debt Obligations

     As discussed in more detail in Note 4, we have commitments to pay interest and outstanding principal balances on our notes and bonds payable as follows (dollars in thousands):

                                         
                    Contractual                
    Balance at           Interest   Interest        
    September 30, 2002   Maturity Date   Rate at 6/30/02   Payments   Principal Payments
   
 
 
 
 
Unsecured Credit Facility due 2004
  $ 73,000       7/04     LIBOR +1.15%   Quarterly   At maturity
Senior Notes due 2006
    70,000       4/06       9.49%   Semi-Annual   $20.3 million in
 
                                  2004, 2005 and $29.4
 
                                  million in 2006
Senior Notes due 2011
    315,163       5/11       8.125%   Semi-Annual   At maturity
Mortgage notes payable
    73,186       9/04-7/26       7.22%-8.50%   Monthly   Monthly or at maturity
Other note payable
    3,500       7/05       7.53%   Semi-Annual   Semi-Annual
 
   
                                 
 
  $ 534,849                                  

15


Table of Contents

     In 2001, we focused on reorganizing our debt structure and repaying or replacing debt instruments that have shorter maturities with debt instruments having longer maturities. As a result of these efforts, at September 30, 2002, substantially all of our outstanding principal debt balances are due after 2003. Further, at October 31, 2002, we had borrowing capacity remaining of $84.0 million under our Unsecured Credit Facility due 2004.

     Our senior debt is rated Baa3, BBB-, and BBB by Moody’s Investors Service, Standard and Poor’s Investor Service, and Fitch Ratings, respectively. For the nine months ended September 30, 2002, our earnings covered fixed charges at a ratio of 3.30 to 1.00. At September 30, 2002, our stockholders’ equity totaled approximately $900.0 million and our debt to total capitalization ratio, on a book basis, was approximately 0.367 to 1.

     At September 30, 2002, we were in compliance with the debt covenant requirements under our various debt instruments.

     Following the reorganization of our debt structure in 2001, our outstanding debt was primarily fixed rate. Our practice and objective has been to protect ourselves against changes in the fair value of our debt that result from changes in market interest rates by maintaining a mix of variable and fixed rate debt. In order to accomplish this objective, in June 2001, we entered into interest rate swap agreements with two lending institutions for notional amounts totaling $125.0 million which are expected to offset changes in the fair value of $125.0 million of the Senior Notes due 2011. In both interest rate swaps, we receive a 8.125% fixed rate and pay a variable rate of LIBOR plus 1.99%. The swaps are not callable for the first five years. After five years, the swaps are callable, at fair value, by either party if, and only if, the other party is downgraded below investment grade by two or more rating agencies. These derivative instruments meet all requirements of a fair value hedge and are accounted for using the “shortcut method” as set forth in Financial Accounting Standards Board Statement No. 133. As such, changes in fair value will have no impact on the income statement. At September 30, 2002, the aggregate fair value totaling $16.6 million of our hedge is reported in other assets with an offsetting increase to the Senior Notes due 2011 included in notes and bonds payable on our balance sheet.

Shelf Registration

     As of September 30, 2002, we could issue an aggregate of approximately $171.6 million of securities remaining under our currently effective registration statement. Should the market permit, we may issue securities under this registration statement. We may, under certain circumstances, borrow additional amounts in connection with the renovation or expansion of our properties, the acquisition or development of additional properties or, as necessary, to meet distribution requirements for REITs under the Internal Revenue Code. We may raise additional capital or make investments by issuing, in public or private transactions, our equity and debt securities, but the availability and terms of any such issuance will depend upon market and other conditions.

Security Deposits and Letters of Credit

     As of September 30, 2002, we held approximately $6.8 million in letters of credit, security deposits, debt service reserves or capital replacement reserves. Generally, we may, at our discretion and upon notification to the operator, draw upon these instruments if there are any defaults under the leases or mortgage notes with our operators.

16


Table of Contents

Dispositions

     During the third quarter of 2002, we sold three ancillary hospital facilities totaling 201,600 square feet in Richmond, Virginia; a 21,120 square foot assisted living facility in West Columbia, South Carolina; a 44,300 square foot physician clinic in Methuen, Massachusetts; and a 41,880 square foot physician clinic in Birmingham, Alabama for aggregate net proceeds totaling approximately $46.4 million resulting in a net gain of approximately $242,000. Further, we received approximately $5.7 million in net proceeds from the repayment of four mortgage notes. These funds were used to partially repay the Unsecured Credit Facility due 2004 and for general corporate purposes.

Construction in Progress

     As of September 30, 2002, we had a net investment of approximately $9.9 million in build-to-suit developments in progress that have a total remaining funding commitment of approximately $0.5 million. We intend to fund these commitments with internally generated cash flows, proceeds from the Unsecured Credit Facility due 2004, proceeds from the sale of additional assets, proceeds from additional repayments of mortgage notes receivable, or additional capital market financing.

Dividends

     On July 23, 2002, our Board of Directors declared an increase in the quarterly common stock dividend from $0.595 per share ($2.38 annualized) to $0.60 per share ($2.40 annualized) payable to stockholders of record on August 15, 2002. This dividend was paid on September 5, 2002. On October 22, 2002, our Board of Directors declared another increase in the quarterly common stock dividend to $0.605 per share ($2.42 annualized) payable to stockholders of record on November 15, 2002. This dividend is payable on December 5, 2002 and relates to the period July 1, 2002 through September 30, 2002. While we have no present plans to change our quarterly common stock dividend policy, the dividend policy is reviewed each quarter by our board of directors.

Redemption of Preferred Stock

     On September 30, 2002, we redeemed all of our 8 7/8% Series A Voting Cumulative Preferred Stock at a redemption price of $25.00 per share, plus accrued dividends of $0.18896 per share from August 30, 2002 to the redemption date, for a total redemption price of $25.18896 per share. The aggregate cost of the redemption was $75,566,881.

Common Stock Repurchase Program

     On October 24, 2002, we announced that our Board of Directors authorized management to repurchase up to one million shares of the Company’s common stock at such times and upon such terms as management may determine.

Liquidity

     Under the terms of the leases and other financial support agreements we have relating to most of the properties, the tenants or healthcare providers are generally responsible to pay for operating expenses and taxes relating to our properties. As a result of these arrangements, with limited exceptions not material to our overall performance, we do not believe any increases in the property operating expenses or taxes would significantly impact our operating results during the respective terms of the agreements. We anticipate entering into similar arrangements with respect to any additional properties we acquire or develop. After the term

17


Table of Contents

of the leases or financial support agreements, or in the event the financial obligations required by the agreement are not met, we anticipate that any expenditures we might become responsible for in maintaining the properties will be funded by occupancy tenants, by cash from operations and, in the case of major expenditures, possibly by borrowings. To the extent that unanticipated expenditures or significant borrowings are required, our cash available for distribution and liquidity may be adversely affected.

     We plan to continue to meet our liquidity needs, including funding additional investments in 2002, paying quarterly dividends and funding debt service from our cash flows, proceeds from the Unsecured Credit Facility due 2004, proceeds from additional repayments of mortgage notes receivable, proceeds from the sale of real estate investments, or additional capital market financing. We believe that our liquidity and sources of capital are adequate to satisfy our cash requirements. We cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to us in sufficient amounts to meet our liquidity needs.

Impact of Inflation

     Inflation has not significantly affected our earnings due to the moderate inflation rate in recent years and the fact that most of our leases and financial support arrangements require tenants and sponsors to pay all or some portion of the increases in operating expenses, thereby reducing our risk of the adverse effects of inflation. In addition, inflation will have the effect of increasing gross revenue we are to receive under the terms of our leases and financial support arrangements. Leases and financial support arrangements vary in the remaining terms of obligations from one to 22 years, further reducing our risk of any adverse effects of inflation. Interest payable under the interest rate swaps and the Unsecured Credit Facility due 2004 is calculated at a variable rate; therefore, the amount of interest payable under the swaps and this debt will be influenced by changes in short-term rates, which tend to be sensitive to inflation. Generally, changes in inflation and interest rates tend to move in the same direction. During periods where interest rate increases outpace inflation, our operating results should be negatively impacted. Likewise, when increases in inflation outpace increases in interest rates, our operating results should be positively impacted.

Market Risk

     We are exposed to market risks, in the form of changing interest rates, on our debt and mortgage notes receivable. We have no market risk with respect to foreign currency fluctuations. Management uses daily monitoring of market conditions and analytical techniques to manage this risk. During 2001, we significantly changed our debt structure. See Liquidity and Capital Resources in this Form 10-Q for further discussion. Also, see pages 8 and 9 of Exhibit 13 “Annual Report to Shareholders” of the Company’s Form 10-K for the fiscal year ended December 31, 2001.

Cautionary Language Regarding Forward Looking Statements

     This Form 10-Q and other materials we have filed or may file with the Securities and Exchange Commission, as well as information included in oral statements or other written statements made, or to be made, by senior management, contain, or will contain, disclosures which are “forward-looking statements.” Forward-looking statements include all statements

18


Table of Contents

that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “believe,” “intend,” “plan,” “estimate,” “project,” “continue,” “should” and other comparable terms. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of risks and uncertainties that could significantly affect our current plans and expectations and future financial condition and results. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Shareholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in our filings and reports. For a detailed discussion of our risk factors, please refer to our filings with the Securities and Exchange Commission, including our Annual Report to Shareholders on Form 10-K for the year ended December 31, 2001.

19


Table of Contents

Item 4. Controls and Procedures

     Within the 90 days prior to the date of this report, we carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-14. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in our periodic SEC filings.

     During the quarter ended September 30, 2002, the Company initiated two internal control improvements. We hired a Certified Internal Auditor as the Company’s internal risk manager. The internal risk manager will evaluate risks and perform tests of the Company’s systems of internal controls and report findings to management and the audit committee. The internal risk manager’s initial tasks are focused on establishing an internal audit department framework, completing internal risk assessment of functional areas, and developing audit plans of the Company’s systems. The internal risk manager met with the audit committee of the board of directors in October 2002 to present and discuss a proposed audit plan for 2002 and 2003.

     In addition, the Company began review and improvement of the internal control process to be employed in the Company’s new development projects. The purpose of this review was to evaluate the current processes and integrate proposed improvements to the processes. The improvements are intended to enhance understanding of the responsibilities and accountabilities of each party to the construction process, improve communication among the parties throughout the process, manage the risks inherent in the development process and enhance the effectiveness and timeliness of information about assets under development. These plans were also discussed with the audit committee of the board of directors in October 2002.

20


Table of Contents

PART II — OTHER INFORMATION

Item 6. Reports on Form 8-K

     During the third quarter of 2002, we furnished the following reports on Form 8-K/8-Ka in accordance with Regulation FD.

             
Date of Earliest            
Event Reported   Date Furnished   Items Reported

 
 
July 25, 2002   July 25, 2002   Item 7. Financial Statements and Exhibits
        Item 9. Regulation FD Disclosure
             
August 12, 2002   August 12, 2002   Item 7. Financial Statements and Exhibits
        Item 9. Regulation FD Disclosure
             
August 14, 2002   August 14, 2002   Item 7. Financial Statements and Exhibits
        Item 9. Regulation FD Disclosure

21


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
    HEALTHCARE REALTY TRUST INCORPORATED
 
       
 
    By:   /s/ Timothy G. Wallace

Timothy G. Wallace
Executive Vice President and Chief Financial Officer

Date: November 14, 2002

22


Table of Contents

Healthcare Realty Trust Incorporated

Quarterly Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David R. Emery, certify that:

     1.     I have reviewed this quarterly report on Form 10-Q of Healthcare Realty Trust Incorporated;

     2.     Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

     3.     Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

     4.     The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

       a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

       b) evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

       c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

     5.     The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

       a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

23


Table of Contents

       b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

     6.     The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

         
Date:   November 14, 2002   /s/ David R. Emery

David R. Emery
Chairman of the Board and Chief Executive Officer

24


Table of Contents

Healthcare Realty Trust Incorporated
Quarterly Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Timothy G. Wallace, certify that:

     1.     I have reviewed this quarterly report on Form 10-Q of Healthcare Realty Trust Incorporated;

     2.     Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

     3.     Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

     4.     The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

       a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

       b) evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

       c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

     5.     The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

       a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

25


Table of Contents

       b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

     6.     The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

         
Date:   November 14, 2002    
 
        /s/ Timothy G. Wallace

Timothy G. Wallace
Executive Vice President and Chief Financial Officer

26